Need Help?
Copied to clipboard!

Whole-exome sequencing data from a phase 2 trial of dasatinib for patients with relapsed or refractory nodal T follicular helper cell lymphomas

Whole-exome sequencing (WES) analysis data from tumor tissues of 14 patients with T follicular helper cell lymphomas enrolled in a phase 2 trial of dasatinib for relapsed or refractory nodal disease.

Cite

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000001765 HiSeq X Ten 14